Bravecto

Bravecto is a globally recognised animal health brand owned by MSD Animal Health, known as Merck Animal Health in the United States and Canada. The brand specialises in long lasting parasite protection and offers a range of oral chews and topical spot on treatments designed to kill fleas and paralysis ticks.

Their signature products provide extended coverage with the chewable tablets offering three months of protection and the spot on solution providing up to six months of defence from a single dose. 

As a core division of the publicly traded Merck and Co, MSD Animal Health continues to expand the Bravecto portfolio with recent innovations such as once yearly injectable formulations. The range is ideal for pet parents researching high compliance preventative care that is safe for puppies from eight weeks of age and suitable for breeding, pregnant, or lactating dogs.